Strides Pharma Science Ltd

Strides Pharma Science Ltd financial statements

Strides Pharma Science Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueINR 48.59BEODHD
Net incomeINR 5.56BEODHD
Cash and equivalentsINR 2.13BEODHD
Total debtINR 17.58BEODHD

Strides Pharma Science Ltd financials on 6ix · Strides Pharma Science Ltd on 6ix